SEC Form 4 · accession 0001415889-17-001795
Medite Cancer Diagnostics, Inc. · MDIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan Weisman
Officer — CHIEF FINANCIAL OFFICER
Period of report
Apr 26, 2017
Accepted (ET)
Nov 16, 2017 · 12:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000075439
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 26, 2017 | A | 200,000 | $0.81 | A | 200,000 | D |
Table II — derivative securities
No Table II lines on this filing.